A Decision Analysis of Allogeneic Stem Cell Transplantation for MDS: Delayed Transplantation for Low Risk MDS Is Associated with Imporved Outcome

Reviewer: Julie Draznin Maltzman, MD
OncoLink
Ultima Vez Modificado: 9 de diciembre del 2002

Translation for this article does not exist

Blogs

The Power of a Cancer Support Group
by Bob Riter
May 26, 2016